{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.666.5.2460","meta":{"versionId":"12","lastUpdated":"2014-06-30T01:00:02.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.2460","version":"20140630","name":"Influenza Vaccine Administration ICD10PCS","status":"active","date":"2014-06-30T01:00:02-04:00","publisher":"Lantana","compose":{"include":[{"system":"http://www.icd10data.com/icd10pcs","version":"2022","concept":[{"code":"3E0134Z","display":"Introduction of Serum, Toxoid and Vaccine into Subcutaneous Tissue, Percutaneous Approach"},{"code":"3E0234Z","display":"Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach"}]}]},"expansion":{"identifier":"urn:uuid:41ea2c4c-171a-4f32-bfad-6e03309610ba","timestamp":"2022-06-10T08:49:33-04:00","total":2,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0134Z","display":"Introduction of Serum, Toxoid and Vaccine into Subcutaneous Tissue, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0234Z","display":"Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach"}]}}